Medicare Enrolled
Dr. Syed Raza, M.D.
Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Raza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raza
Dr. Syed Raza is a medical oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Raza performed 6,022 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Raza received a total of $19,119 from 86 pharmaceutical and/or device companies across 909 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 43% volume in TX
$19,119 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,022
Medicare services
Top 43% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,580 | $6 | $16 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,264 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 1,008 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
202 | $64 | $176 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
187 | $94 | $249 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
171 | $11 | $27 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
147 | $22 | $56 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
107 | $98 | $251 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
97 | $8 | $16 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
59 | $21 | $54 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
55 | $1 | $3 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
52 | $1 | $2 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
37 | $47 | $123 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
25 | $21 | $109 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $50 | $176 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $110 | $323 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.8% high complexity
86.2% medium
9.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,119
Total received (2018-2024)
Avg $2,731/year across 7 years
Top 31% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
909
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,300
2023
$1,676
2022
$1,535
2021
$1,859
2020
$1,328
2019
$4,606
2018
$3,813
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$718
AstraZeneca Pharmaceuticals LP
$400
Janssen Biotech, Inc.
$281
Merck Sharp & Dohme LLC
$240
Genentech USA, Inc.
$218
E.R. Squibb & Sons, L.L.C.
$187
Celgene Corporation
$136
PFIZER INC.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$119
GENZYME CORPORATION
$115
Lilly USA, LLC
$102
US Oncology Corporate, Inc.
$95
Daiichi Sankyo Inc.
$94
GlaxoSmithKline, LLC.
$78
ABBVIE INC.
$70
ADC Therapeutics America, Inc.
$69
SOBI, INC
$68
Incyte Corporation
$65
BeiGene USA, Inc.
$61
Bayer Healthcare Pharmaceuticals Inc.
$61
Regeneron Healthcare Solutions, Inc.
$60
Karyopharm Therapeutics Inc.
$57
Eisai Inc.
$54
Rigel Pharmaceuticals, Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$47
ARRAY BIOPHARMA INC
$46
Pharmacosmos Therapeutics Inc.
$46
Sirtex Medical Inc
$45
JAZZ PHARMACEUTICALS INC.
$45
Amneal Pharmaceuticals LLC
$38
Ipsen Biopharmaceuticals, Inc
$37
Spectrum Pharmaceuticals Inc.
$37
EMD Serono, Inc.
$35
Astellas Pharma US Inc
$34
Genmab U.S., Inc.
$28
Sumitomo Pharma America, Inc.
$27
TAIHO ONCOLOGY, INC.
$26
Stemline Therapeutics Inc.
$25
Alexion Pharmaceuticals, Inc.
$20
Octapharma USA, Inc.
$20
Biocon Biologics Inc
$20
SERVIER PHARMACEUTICALS LLC
$20
Tempus AI, Inc
$19
TerSera Therapeutics LLC
$19
Blueprint Medicines Corporation
$19
Azurity Pharmaceuticals, Inc.
$18
Immunocore Limited
$18
Aveo Pharmaceuticals, Inc.
$16
Acrotech Biopharma Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Geron Corporation
$15
SpringWorks Therapeutics, Inc.
$14
SHIELD THERAPEUTICS INC
$14
Top 3 companies account for 32.5% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$1,772
Novartis Pharmaceuticals Corporation
$1,386
Genentech USA, Inc.
$1,349
Incyte Corporation
$1,282
Janssen Biotech, Inc.
$1,206
AstraZeneca Pharmaceuticals LP
$979
Bayer HealthCare Pharmaceuticals Inc.
$909
E.R. Squibb & Sons, L.L.C.
$881
Amgen Inc.
$826
PFIZER INC.
$632
Merck Sharp & Dohme Corporation
$570
Lilly USA, LLC
$470
Celgene Corporation
$382
Merck Sharp & Dohme LLC
$381
Astellas Pharma US Inc
$348
Daiichi Sankyo Inc.
$277
GENZYME CORPORATION
$267
Takeda Pharmaceuticals U.S.A., Inc.
$237
Eisai Inc.
$225
Puma Biotechnology, Inc.
$208
EISAI INC.
$208
Teva Pharmaceuticals USA, Inc.
$203
US Oncology Corporate, Inc.
$192
Exelixis Inc.
$154
AVEO Pharmaceuticals, Inc.
$153
Myriad Genetic Laboratories, Inc.
$152
Gilead Sciences, Inc.
$140
AbbVie, Inc.
$136
ADC Therapeutics America, Inc.
$135
GlaxoSmithKline, LLC.
$134
Rigel Pharmaceuticals, Inc.
$133
Regeneron Healthcare Solutions, Inc.
$127
Pharmacyclics LLC, An AbbVie Company
$127
TerSera Therapeutics LLC
$112
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
Karyopharm Therapeutics Inc.
$111
Seagen Inc.
$106
ABBVIE INC.
$99
SOBI, INC
$98
Kyowa Kirin, Inc.
$89
Taiho Oncology, Inc.
$87
Bayer Healthcare Pharmaceuticals Inc.
$82
Janssen Pharmaceuticals, Inc
$76
ARRAY BIOPHARMA INC
$76
Ipsen Biopharmaceuticals, Inc
$75
Medtronic Vascular, Inc.
$73
Helsinn Therapeutics (U.S.), Inc.
$71
Amneal Pharmaceuticals LLC
$70
JAZZ PHARMACEUTICALS INC.
$70
Foundation Medicine, Inc.
$65
AMAG Pharmaceuticals, Inc.
$65
Alexion Pharmaceuticals, Inc.
$63
BeiGene USA, Inc.
$61
Verastem, Inc.
$56
Jazz Pharmaceuticals Inc.
$54
Sumitomo Pharma America, Inc.
$50
EMD Serono, Inc.
$50
PUMA BIOTECHNOLOGY, INC.
$47
Pharmacosmos Therapeutics Inc.
$46
Sirtex Medical Inc
$45
Clovis Oncology, Inc.
$38
Spectrum Pharmaceuticals Inc.
$37
Blueprint Medicines Corporation
$31
Genmab U.S., Inc.
$28
Seattle Genetics, Inc.
$27
TAIHO ONCOLOGY, INC.
$26
Stemline Therapeutics Inc.
$25
Adaptive Biotechnologies Corporation
$24
Deciphera Pharmaceuticals Inc.
$20
Octapharma USA, Inc.
$20
Biocon Biologics Inc
$20
SERVIER PHARMACEUTICALS LLC
$20
Tempus AI, Inc
$19
Array BioPharma Inc.
$18
Azurity Pharmaceuticals, Inc.
$18
Immunocore Limited
$18
Aveo Pharmaceuticals, Inc.
$16
Acrotech Biopharma Inc.
$16
Agios Pharmaceuticals, Inc.
$15
CTI BioPharma Corp.
$15
Geron Corporation
$15
SpringWorks Therapeutics, Inc.
$14
SHIELD THERAPEUTICS INC
$14
Shield Therapeutics Inc
$13
Dova Pharmaceuticals
$13
Advanced Accelerator Applications
$12
Top 3 companies account for 23.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BENDEKA · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Epkinly · Erivedge · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RECOTHROM · ROLVEDON · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYNAGIS · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tecartus · Tecentriq · Tibsovo · Trodelvy · Truxima · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VOTRIENT · VPRIV · VYXEOS · Vectibix · VenaSeal · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xtandi · Yescarta · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
37
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SAN ANTONIO STATE HOSP STATE SCHOOL
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Raza is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Raza experienced with epoetin alfa injection (retacrit) for anemia?
Based on Medicare claims data, Dr. Raza performed 2,580 epoetin alfa injection (retacrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Raza receive payments from pharmaceutical companies?
Yes. Dr. Raza received a total of $19,119 from 86 companies across 909 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raza's costs compare to other medical oncologists in San Antonio?
Dr. Raza's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in San Antonio
Browse medical oncologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology